Keywords: Hepatitis B, Tretment, UK, NICE draft guideline, Gilead, Viread, Preveon, Novartis, Sebivo, Bristol-Myers, Baraclude

UK's NICE issues draft guideline for diagnosis and management of hepatitis B

Article | 17 January 2013

Print This

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) is currently developing a new clinical guideline on ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in